Verywell Health, November 29 2022.
Triple-positive breast cancer has three features that influence its prognosis and set it apart from other subtypes of breast cancer. It grows in response to two hormones and makes a lot of a protein called human epidermal growth factor receptor 2 (HER2).
While these features mean cancer grows fast, it also means that it has many treatment options. It responds to both hormone treatments and targeted treatments against HER2. However, new research suggests that it may not respond as well to these drugs as other breast cancers with HER2. Read More >